Colin MD Broom's Net Worth
$14.1 Million
Who is Colin MD Broom?
Colin MD Broom has an estimated net worth of $14.1 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Nabriva Therapeutics AG, VIROPHARMA INC, and NPS PHARMACEUTICALS INC.
SEC CIK
Colin MD Broom's CIK is 0001289946
Past Insider Trading and Trends
2011 was Colin MD Broom's most active year for acquiring shares with 15 total transactions. Colin MD Broom's most active month to acquire stocks was the month of December. 2014 was Colin MD Broom's most active year for disposing of shares, totalling 32 transactions. Colin MD Broom's most active month to dispose stocks was the month of December. 2012 saw Colin MD Broom paying a total of $702,090.04 for 183,393 shares, this is the most they've acquired in one year. In 2014 Colin MD Broom cashed out on 888,861 shares for a total of $8,705,872.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nabriva Therapeutics Plc No price found
Chief Executive OfficerColin MD Broom owns 1,595 units of Ordinary Shares. In the year 2017 Colin MD Broom filed a total of 1 filing.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 157.41K |
—
|
—
| 157.41K |
Jun 23
| |||
No matching records found |
Nabriva Therapeutics AG (NBRVF) Snapshot price: $0.000001
CEO & DirectorColin MD Broom owns 36,523 units of Ordinary Shares which is worth $0.04 and 97,151 units of Ordinary Shares F1 which is worth $0.10. In the year 2016 Colin MD Broom acquired a total of 130,265 shares in Nabriva Therapeutics AG at a cost of $106,878.27, Colin also disposed a total of 37,288 shares of Nabriva Therapeutics AG equalling to $50,950.51.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -12.75% | -5.34K |
$0.19 | -$1,015.48 | 36.52K |
Aug 2
| |||
Form 4
| -1.25% | -531.00 |
$1.20 | -$637.20 | 41.86K |
Aug 2
| |||
Form 4
| +70.30% | 17.5K |
—
|
—
| 42.39K |
Jul 28
| |||
Form 4
| +10.03% | 22.69K |
$0.65 | -$7,165.05 | 248.94K |
Aug 19 - Aug 20
| |||
Form 4
| +8.38% | 17.5K |
—
|
—
| 226.25K |
Jul 29
| |||
Form 4
| +5.13% | 10.18K |
$2.03 | $20,668.47 | 208.75K |
Aug 30
| |||
Form 4/A
| -7.49% | -10.18K |
$2.07 | -$21,066.39 | 125.72K |
Aug 21
| |||
Form 4
| +23.08% | 23.57K |
$2.07 | -$21,066.39 | 125.72K |
Aug 19 - Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| +5.15% | 5K |
$3.72 | $18,600.00 | 102.15K |
Jun 22
| |||
Form 4
| +11.47% | 10K |
$4.60 | $46,000.00 | 97.15K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +3.06% | 2.59K |
$8.35 | $21,609.80 | 87.15K |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VIROPHARMA INC No price found
VP & Chief Scientific OfficerColin MD Broom owns 15,113 units of Common Stock for Sales. Colin MD Broom used to own units in Common stock but no longer holds any shares there.acquired a total of 513,519 shares in VIROPHARMA INC at a cost of $2,558,764.33, Colin also disposed a total of 543,044 shares of VIROPHARMA INC equalling to $15,587,539.07.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -154.06K |
$50.00 |
—
|
0
|
Jan 24
| |||
Form 4
| +380.59% | 122K |
$27.51 | -$262,397.71 | 154.06K |
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4/A
| -46.46% | -17.50K |
$22.53 | -$394,301.25 | 20.17K |
Scheduled
|
Dec 24
| ||
Form 4
| +49.59% | 10K |
$1.84 | $18,400.00 | 30.17K |
Scheduled
|
Dec 27
| ||
Form 4
|
—
|
0
|
$12.19 | -$362,101.25 | 37.67K |
Scheduled
|
Dec 24
| ||
Form 4
|
—
|
0
|
$16.38 | -$1,153,525.89 | 37.67K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +90.03% | 17.5K |
$1.84 | $32,200.00 | 36.94K |
Dec 23
| |||
Form 4
|
—
|
0
|
$17.02 | -$831,250.00 | 19.44K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$15.28 | -$658,072.45 | 19.44K |
Scheduled
|
Dec 12 - Dec 13
| ||
Form 4
|
—
|
0
|
$13.46 | -$301,802.00 | 19.44K |
Nov 7
| |||
Form 4
|
—
|
0
|
$11.68 | -$762,101.32 | 19.44K |
Oct 31 - Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +16.73% | 2.5K |
$1.84 | $4,600.00 | 17.44K |
Dec 31
| |||
Form 4
|
—
|
0
|
$7.55 | -$342,565.60 | 15.11K |
Sep 9 - Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| -45.17% | -9.97K |
$8.70 | -$312,957.27 | 12.1K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NPS PHARMACEUTICALS INC No price found
InvestorColin MD Broom used to own units in Common Stock but no longer holds any shares there.acquired a total of 45,638 shares in NPS PHARMACEUTICALS INC, Colin also disposed a total of 30,413 shares of NPS PHARMACEUTICALS INC equalling to $1,171,712.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -24.31K |
$46.00 | -$1,118,398.00 |
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +166.44% | 15.19K |
—
|
—
| 24.31K |
Feb 12 - Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
∞
| 9.13K |
$8.74 | -$53,314.00 | 9.13K |
Scheduled
|
Feb 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
∞
| 15.22K |
—
|
—
| 15.22K |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |